Cargando…
Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing
Genome-editing technology has emerged as a potential tool for treating incurable diseases for which few therapeutic modalities are available. In particular, discovery of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system together with the design of single-guide RNAs (s...
Autores principales: | Kim, Dongyoon, Le, Quoc-Viet, Wu, Yina, Park, Jinwon, Oh, Yu-Kyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766488/ https://www.ncbi.nlm.nih.gov/pubmed/33353099 http://dx.doi.org/10.3390/pharmaceutics12121233 |
Ejemplares similares
-
Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
por: Ju, Hyemin, et al.
Publicado: (2022) -
In vivo fate and intracellular trafficking of vaccine delivery systems()
por: Lee, Jaiwoo, et al.
Publicado: (2022) -
Delivery Aspects of CRISPR/Cas for in Vivo Genome
Editing
por: Wilbie, Danny, et al.
Publicado: (2019) -
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021) -
Lipid Nanoparticle-Mediated Lymphatic Delivery of Immunostimulatory Nucleic Acids
por: Kim, Dongyoon, et al.
Publicado: (2021)